{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:15:09Z","timestamp":1787652909054,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020874","name":"Trevena","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.burns.2024.107343","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T11:13:17Z","timestamp":1732965197000},"page":"107343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A prospective, historical-controlled evaluation of oliceridine for moderate or severe pain in patients with acute burn injuries (RELIEVE)"],"prefix":"10.1016","volume":"51","author":[{"given":"David M.","family":"Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine A.","family":"Todor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.burns.2024.107343_bib1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cps.2017.05.005","article-title":"Principles of burn pain management","volume":"44","author":"James","year":"2017","journal-title":"Clin Plast Surg"},{"issue":"6","key":"10.1016\/j.burns.2024.107343_bib2","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jbcr\/iraa120","article-title":"American Burn Association Guidelines on the management of acute pain in the adult burn patient: a review of the literature, a compilation of expert opinion and next steps","volume":"41","author":"Romanowski","year":"2020","journal-title":"J Burn Care Res"},{"issue":"4","key":"10.1016\/j.burns.2024.107343_bib3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/BCR.0b013e318236fe4f","article-title":"Efficacy and safety of procedural sedation and analgesia for burn wound care","volume":"33","author":"Thompson","year":"2012","journal-title":"J Burn Care Res"},{"issue":"1","key":"10.1016\/j.burns.2024.107343_bib4","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/BCR.0000000000000423","article-title":"Sedation and analgesia for dressing change: a survey of American Burn Association Burn Centers","volume":"38","author":"Myers","year":"2017","journal-title":"J Burn Care Res"},{"issue":"2","key":"10.1016\/j.burns.2024.107343_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.burns.2017.07.018","article-title":"Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: a retrospective chart review","volume":"44","author":"Kaul","year":"2018","journal-title":"Burns"},{"issue":"2","key":"10.1016\/j.burns.2024.107343_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/BCR.0b013e31828a4828","article-title":"Gabapentin is ineffective as an analgesic adjunct in the immediate postburn period","volume":"35","author":"Wibbenmeyer","year":"2014","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2024.107343_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.physiol.69.022405.154749","article-title":"Beta-arrestins and cell signaling","volume":"69","author":"DeWire","year":"2007","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"10.1016\/j.burns.2024.107343_bib8","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"Pt 3","key":"10.1016\/j.burns.2024.107343_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1242\/jcs.115.3.455","article-title":"The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals","volume":"115","author":"Luttrell","year":"2002","journal-title":"J Cell Sci"},{"issue":"3","key":"10.1016\/j.burns.2024.107343_bib10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine","volume":"344","author":"DeWire","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.burns.2024.107343_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/JPR.S171013","article-title":"APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the micro-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy","volume":"12","author":"Viscusi","year":"2019","journal-title":"J Pain Res"},{"issue":"7","key":"10.1016\/j.burns.2024.107343_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/papr.12801","article-title":"APOLLO-2: a randomized, placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the mu-opioid receptor, for management of moderate to severe acute pain following abdominoplasty","volume":"19","author":"Singla","year":"2019","journal-title":"Pain Pract"},{"key":"10.1016\/j.burns.2024.107343_bib13","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.2147\/JPR.S217563","article-title":"ATHENA: a phase 3, open-label study of the safety and effectiveness of oliceridine (TRV130), a G-protein selective agonist at the micro-opioid receptor, in patients with moderate to severe acute pain requiring parenteral opioid therapy","volume":"12","author":"Bergese","year":"2019","journal-title":"J Pain Res"},{"issue":"3","key":"10.1016\/j.burns.2024.107343_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/mol.104.003822","article-title":"Arrestin-independent internalization of G protein-coupled receptors","volume":"66","author":"van Koppen","year":"2004","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.burns.2024.107343_bib15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/jbcr\/irad087","article-title":"Evaluation of the role of a clinical pharmacist on medication management in an adult burn clinic via a collaborative drug therapy management protocol","volume":"44","author":"Boyd","year":"2023","journal-title":"J Burn Care Res"},{"issue":"2","key":"10.1016\/j.burns.2024.107343_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.burns.2018.08.004","article-title":"Opioid creep in burn center discharge regimens: doubled amounts and complexity of narcotic prescriptions over seven years","volume":"45","author":"Tully","year":"2019","journal-title":"Burns"},{"issue":"4","key":"10.1016\/j.burns.2024.107343_bib17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.burns.2020.09.009","article-title":"Prescribing patterns of opioids and adjunctive analgesics for patients with burn injuries","volume":"47","author":"Yeung","year":"2021","journal-title":"Burns"},{"issue":"6","key":"10.1016\/j.burns.2024.107343_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.18626","article-title":"Trends in the use of gabapentinoids and opioids in the postoperative period among older adults","volume":"6","author":"Bongiovanni","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.burns.2024.107343_bib19","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1111\/jgs.18005","article-title":"Prolonged use of newly prescribed gabapentin after surgery","volume":"70","author":"Bongiovanni","year":"2022","journal-title":"J Am Geriatr Soc"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417924003838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417924003838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T02:43:05Z","timestamp":1739241785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417924003838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0305417924003838"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2024.107343","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prospective, historical-controlled evaluation of oliceridine for moderate or severe pain in patients with acute burn injuries (RELIEVE)","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2024.107343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107343"}}